26 results
Thumbnail

D2.115 - Association of chemokine levels with types of reactions after alcohol consumption in patients with nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD)

Thumbnail

D2.116 - Occupational asthma due to Chinese yeast, Yeast and Peptone

Thumbnail

D2.117 - The interaction of exposure to air pollutants and inflammatory markers on lung function and asthma symptoms in asthmatic patients

Thumbnail

D2.118 - Eosinophilic Esophagitis and Atopy: A Shared Mechanism of Type 2 Inflammation

Thumbnail

D2.119 - Real-life experience in eosinophilic granulomatosis with polyangiitis (EGPA) after 12 months with mepolizumab 300mg in specialized autoimmune and asthma units in an Universitary Hospital

Thumbnail

D2.122 - Dupilumab-Induced Diffuse Eosinophilic Drug Rash with Hypereosinophilia in a Patient with Idiopathic Pulmonary Fibrosis and Severe Asthma Exacerbation: A First Case Report

Thumbnail

D2.123 - The impact of wartime environmental change on the frequency of asthma diagnoses

Thumbnail

D2.124 - Clinical Characteristics and Predictors in Patients with Difficult-to-Treat Asthma

Thumbnail

D2.125 - Occupational asthma in hairdressers due to hair dyes containing para-amino compounds

Thumbnail

D2.127 - The bacterial lysate OM-85 mitigates HDM-induced allergic inflammation through the airway epithelial cell- macrophage crosstalk

Thumbnail

D2.128 - Sarcoid-like reaction induced by aspirin therapy after aspirin desensitization in a patient with aspirin-exacerbated respiratory disease

Thumbnail

D2.129 - Bacterial Species Cultured from Sputum of Asthmatic Patients with Bronchiectasis: Impact of Inhaled Corticosteroid Use

Thumbnail

D2.130 - Genetic Associations of TSLP SNPs with Asthma Susceptibility and Severity

Thumbnail

D2.131 - Classification, early determinants and long-term impact on asthma of the IgG responses to rhinovirus VP1 (RV-VP1): a longitudinal study in two birth cohorts

Thumbnail

D2.132 - Characteristics of Patients with Uncontrolled Severe Asthma Undergoing Biological Therapy Based on Spirometric Response: Our Experience

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis